Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Flutter gets green light for €2.3bn Snai deal

(Sharecast News) - Sports betting and gaming giant Flutter Entertainment has secured regulatory clearance for its €2.3bn acquisition of Italy's Snaitech. In a brief statement released after the London market had closed on Wednesday, Flutter confirmed it had received "all necessary antitrust, gaming and regulatory confirmations" needed to buy Snai.

The deal is now on track to complete by the end of April.

"The acquisition of Snai full aligns with Flutter's strategy to invest in leadership positions in attractive international markets," it said.

"Adding Snai to the Flutter portfolio will consolidate Flutter's leadership position in Italy and create a position of increased scale to capitalise on the growth opportunity in Europe's largest regulated market."

Flutter - the owner of Paddy Power, FanDuel, BetFair and PokerStars, among others - first announced it would buy the Italian business from a subsidiary of Playtech in September.

Part of an aggressive international expansion plan, at the time Flutter said the deal would add to earnings per share immediately.

It also flagged growth opportunities in Italy, noting that just 21% of gross gaming revenue is currently bet online. The compares to around 60% in more established markets such as the UK or Australia.

Flutter, which has its registered head office in Dublin, switched its primary listing to New York last year.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.